key: cord-0920507-s6560414
authors: de Oliveira, Bruno Luciano Carneiro Alves; Campos, Marcos Adriano Garcia; Queiroz, Rejane Christine de Sousa; Alves, Maria Teresa Seabra Soares de Britto e; de Souza, Bruno Feres; dos Santos, Alcione Miranda; da Silva, Antônio Augusto Moura
title: Prevalence and factors associated with covid-19 vaccine hesitancy in Maranhão, Brazil
date: 2021-04-15
journal: Revista de saude publica
DOI: 10.11606/s1518-8787.2021055003417
sha: 0edd873e07206574ea48516b2b58bbeae54fc5db
doc_id: 920507
cord_uid: s6560414

OBJECTIVES: To estimate the prevalence and factors associated with hesitancy in getting the vaccine against SARS-CoV-2 in Maranhão, Brazil. METHODS: This is a cross-sectional population-based study conducted from October 19 to 30, 2020. The estimates were calculated based on clustering, stratification, and non-response. A three-stage sampling was adopted, considering stratum, census tracts, and domicile. After systematic analysis, thirty sectors were selected in each stratum, totaling 150 sectors. Each sector contained a fixed number of 34 households, thus totaling 5,100 households. One individual within each household (resident for at least six months and aged one year or more) was selected by a simple random sampling. We questioned participants about their vaccination intention. Univariate association between independent variables and the outcome were verified using descriptive analysis (weighted frequencies) and Pearson's chi-square test (p < 0.05). Robust multivariate analysis was performed using a three-level hierarchical model. RESULTS: We found 17.5% (95%CI 16.1–19.1%) of the 4,630 individuals interviewed to report hesitancy to be vaccinated against covid-19. After final model adjustment, vaccination hesitancy was statistically higher among residents of the cities of Imperatriz (24.0%; RP = 1.48; IC95% 1.09–2.02) and municipalities of the Grande Ilha de São Luís (20.7%; RP = 1.34; 95%CI 1.02–1.76), female individuals (19.8%; RP = 1.44; 95%CI 1.20–1.75), older adults (22.8%; RP = 1.79; IC95% 1.30–2.46), evangelicals (24.1%; RP = 1.49; 95%CI 1.24–1.79), and those without reported symptoms (18.6%; RP = 1.24; 95%CI 1.02–1.51). We found no statistical differences for other socioeconomic and demographic characteristics, as well as variables related to the labor market, behaviors, and health conditions of the interviewees. CONCLUSION: The prevalence of vaccine hesitancy in Maranhão and its association with individual, contextual, and clinical factors enable us to identify the groups and contexts of greatest resistance, requiring special attention from public strategies to ensure wide vaccination.

In the course of the pandemic, state and local governments in Brazil mobilized strategic actions to control the exposure to SARS-CoV-2 virus. To diminish the magnitude of the disease, the country implemented an extensive list of non-pharmacological interventions (NPI) 1 . However, a permanent solution is more likely to be provided by developing, making available, and implementing effective, safe, and high-quality vaccines against the virus 2 .

Vaccination is one of the most cost-effective ways to prevent diseases. Currently, immunization is estimated to prevent 2-3 million deaths every year and could possibly avoid an additional 1.5 million if global vaccination coverage was improved 3 . Brazil has one of the world's largest public vaccination programs, offering a wide range of vaccines and other special immunobiologicals for specific audiences through regular routine schedule and campaigns. Yet, the program distinctive high coverage has fallen over the past years. In 2019, 89,776,476 million doses of vaccines were administered. Coverage rates ranged from 61.2% in Rio de Janeiro and 63.2% in Maranhão to 90.0% in Mato Grosso do Sul. In 2020, the pandemic scenario led to vaccination suspension, reducing the number of doses (n = 57,519,127) and vaccination rates (32.2% in Amapá, 39.2% in Maranhão, and 66.1% in the Federal District) 4 , causing new outbreaks of vaccine-preventable diseases 5. Although the epidemiological and socioeconomic benefits of immunization programs are well-known, the debate over vaccine hesitancy (reluctance, indecision, or refusal to vaccinate despite availability of vaccination services) has grown worldwide. Such hesitancy poses a global threat to the progress made in combating vaccine-preventable diseases, thus becoming a central issue for immunization programs [6] [7] [8] . Vaccine hesitancy owes to complex causes of varying forms and intensities, based on when and where vaccination occurs, which vaccine is involved, and on which public it is administered 9, 10 . In 2019, the World Health Organization (WHO) included vaccine hesitancy as one of the ten leading threats to global health, proposing strategies for its mitigation along with other non-governmental institutions 3, 6 .

Worldwide, several candidate vaccines against the novel coronavirus are in various stages of development. Some, in more advanced stages of testing, will be feasible for administration between the end of 2020 and the first months of 2021 in most upper and middle income countries 11, 12 . Despite the advance, political polarizations, conspiracy theories, anti-vaccine movements, and vaccine-related concerns have rapidly increased in social networks and traditional media during the covid-19 pandemic. Unverified/incomplete information, rumors, and memes about coronavirus vaccines and origins reach many people faster than complex scientific information 11, 13, 14 , possibly affecting vaccine confidence and acceptance 9, 11 . New vaccines may have restored the hopes of returning to pre-covid normality, but they also raise questions about unknown effects and sparked speculation about potential mandatory vaccination 11, 13, 14 .

Thus, local authorities must employ the available resources to deal with complex ethical and health issues for overcoming vaccine hesitancy. For that, they must know which groups are more resistant to immunization and which strategies should be implemented for preparing the population for vaccination, ensuring high coverage rates and homogeneity levels among different groups and localities. Knowing the prevalence and characteristics associated with vaccine hesitancy in the Brazilian context may help ensuring the effectiveness of immunization programs and campaigns against covid-19.

This study estimated the prevalence and factors associated with vaccine hesitancy in the context of the covid-19 pandemic using a questionnaire on SARS-CoV-2 virus infection, conducted in Maranhão, Brazil.

This is a cross-sectional study conducted with data from the population-based household serological survey entitled "Prevalence of SARS-CoV-2 infection in Maranhão, Brazil," developed in cooperation with the Universidade Federal do Maranhão and the Health Department of Maranhão, from October 19 to 30, 2020. The municipalities of Maranhão were divided into five strata according to 2019 municipal population reported by the Brazilian Institute of Geography and Statistics (IBGE) 15 : Grande Ilha; less than 20,000 inhabitants; from 20,000 to 100,000 inhabitants; more than 100,000 inhabitants, and Imperatriz (second largest in population and economy). The Grande Ilha comprised the state capital, São Luís, and three other neighboring cities.

Sample size was calculated based on the estimated prevalence of SARS-Cov-2 infection of the first survey conducted in the state 16 . In each stratum, sample size was estimated from the following equation:

Where N is the population in each stratum, P the prevalence, and CV the estimates coefficient of variation of the expected prevalence within the strata. A design effect was considered at 2. The study sample consisted of 5,001 individuals: 872 in Stratum 1 (four municipalities); 1,236 in Stratum 2 (122 municipalities); 612 in Stratum 3 (85 municipalities); 1,022 in Stratum 4 (five municipalities); and 1,021 in Stratum 5 (one municipality).

Sample selection was performed in three stages. In the first, census sectors were selected within each stratum. Within sectors, households were selected. Finally, only one individual residing within each household was selected.

In each stratum, sectors were selected from a systematic random sampling, proportional to the number of permanent private households. Thirty sectors were selected, totaling 150 sectors. Sectors with less than 200 households in the 2010 census were grouped with others, respecting their continuity, so that each clustered sector had at least 200 households. The number of sectors and households was retrieved from the 2010 demographic census 17 .

Thirty-four households within each sectors or clusters were selected by systematic sampling, totaling 5,100 households. Likewise, one individual within each household was selected from a simple random sampling based on a list of eligible residents compiled during the interview (resident for at least six months and aged one year or more), totaling 5,100 individuals. The final sample reached a 65.4% response rate (n = 4,630), and the final sample weight considered the three-stage sampling and the response rate.

Data were collected by means of a questionnaire and by drawing 5mL of blood from the chosen individual, and then recorded in the EpiCollect platform from a mobile device 18 .

A laboratory technician and an interviewer, both using personal protective equipment (PPE), comprised data collection teams. Blood was collected to detect the presence of total antibodies (IgM, IgG, and IgA) against SARS-CoV-2 by serological testing using the electro-chemiluminescence immunoassay (ECLIA), the cobas e 601 ® immunoassay analyzer module (Roche Diagnostics), and Elecsys ® Anti-SARS-CoV-2 (Roche Diagnostics) 19, 20 .

In our study, covid-19 vaccine hesitancy was the outcome variable, assessed by the question: "Would you take the covid-19 vaccine if it were available to the population?". Possible answers were: "yes," "no," and "I don't know". For children, the guardian's decision was considered. For reflecting refusal or indecision about immunization, "no" and "I don't know" were classified as "vaccine hesitancy."

A set of independent variables was evaluated. Socioeconomic and demographic variables were: gender, age group (1-19, 20-59, ≥ 60), color/ethnicity (white, mixed race, black), education level (up to complete primary education, complete secondary education, complete tertiary education), household income in reais (< 1,000, 1,000 a< 2,000, ≥ 2,000), health insurance (yes, no), religion (catholic, evangelical, no religion, others), residents per household (1, 2, ≥ 3), and use of public transportation during the pandemic (no, yes). Variables related to the labor market after the pandemic onset were: keep working face-to-face (yes, no, didn't work outside the home before the pandemics), works remotely, even if partially (yes, no, didn't work), lost their job or experienced a reduction in household income (yes, no, didn't work), received Bolsa Família aid (yes, no), received emergency aid (yes, no), and received unemployment insurance benefits (yes, no, didn't work). As for variables related to individuals' behaviors and health conditions, they comprised compliance with non-pharmacological interventions from the pandemic onset (March 2020 was used as reference) until the survey date (October 2020), that is: social isolation (yes, no), use of masks (yes, no), hand hygiene (yes, no), and physical distancing (yes, no); frequency of symptoms 6 possibly related to covid-19 (no symptoms, 1 to 2, ≥ 3); having performed covid-19 diagnostic testing (RT-PCR, rapid test, or serology) before the investigation (yes, no); and SARS-CoV-2 serology identified in the survey (positive, negative).

Statistical analysis was performed in the Stata ® 14 software, considering the complex sampling design and sample weighting. The prevalence of vaccination hesitancy and respective 95% confidence intervals (95%CI) were estimated based on independent variables, whose univariate association was assessed using the Pearson's chi-square test at 5% significance level. Multivariate Poisson analysis was performed using hierarchical modeling ( Figure) . Explanatory variables were arranged at three levels: distal (socioeconomic We verified no statistically significant association (p > 0.05) between vaccine refusal and factors associated with the labor market and interviewees' socioeconomic vulnerability before the pandemic onset (Table 2) . 1.24-1.79), and individuals who experienced no symptoms during the pandemic (PR = 1.24; 95%CI 1.02-1.51) to be more likely to report vaccine hesitancy (Table 4) .

Our results indicate that, if the covid-19 vaccine was available, most interviewees would like to take it. However, we also verified a significant prevalence of vaccine hesitancy among respondents. In the adjustment model, this prevalence was associated with individual, contextual, and clinical characteristics, such as being female, older adult, evangelical, living within the two strata from the cities with the largest population, and not presenting covid-19-related symptoms during the pandemic.

Immunization decisions comprise a complex behavioral phenomenon, involving cultural, geographical, psychosocial, economic, religious, political, cognitive, and gender factors. The causes of vaccine hesitancy are classified into three interrelated categories: lack of confidence (in their efficacy and safety, in the health system providing them, or in managers and policymakers' motivations to recommend them), complacency (low risk perception of acquiring immunopreventable diseases, deeming vaccination unnecessary), and lack of c Adjusted for gender, stratum, age group, religion, compliance with non-pharmacological interventions, covid-19 testing before and during the survey. d The following symptoms were considered: fever, chills, sore throat, cough, dyspnea, anosmia, ageusia, diarrhea, nausea/vomiting, headache, fatigue, and myalgia. They were classified into: no symptoms; one or two symptoms, provided they were not anosmia/hyposmia or ageusia/dysgeusia; three or more symptoms (including anosmia/hyposmia or ageusia/dysgeusia).

convenience (immunization services availability, accessibility, and appeal, including time, place, language, and cultural contexts) 21, 22 .

Research conducted in other countries have also verified a relevant prevalence of hesitancy against SARS-CoV-2 vaccine. A survey conducted with a random sample of 13,426 individuals from 19 countries (whose sum corresponds to 55% of the world's population) found a 28.5% vaccine hesitancy, ranging from 11.4% in China to 45.1% in Russia 9 . In this study, Brazil had the second lowest estimated prevalence (14.7%), below that found in other middle-income countries (India, Mexico and South Africa) 9 and in Maranhão. The prevalence of vaccine hesitancy was 14.0% in Turkey 23 , 31.0% in the United Kingdom 23 , and ranged from 33.0% 10 to 42.4% 24 in the US. As for Israel 25 , studies found a 25.0% prevalence in the overall population, 22.0% in physicians, and 39.0% in nurses.

These results show that vaccine hesitancy varies according to the context. In our research, the capital strata and that of the second largest and richest city in Maranhão presented higher prevalence and likelihood of vaccine refusal than smaller population strata, reaching values close to those observed in countries such as the USA, South Korea, Mexico, India, and Spain 9 . A survey conducted in the US observed a geographic variation in the prevalence of covid-19 vaccine rejection within the country (25.0% to 50.0%) 10 , which may be explained by different epidemic dynamics in each stratum, socioeconomic status, and healthcare access. The covid-19 epidemic in Maranhão began with large cities, more integrated into economic and air transport networks. Early in the pandemic, the cities of São Luís and Imperatriz reported the highest number of cases and deaths within the state. São Luís was the first Brazilian capital to enforce lockdown and one of the first to reopen non-essential retails. Thus, flattening the curves and reopening the economy led to a decrease in the perceived risk of virus transmission. When compared to the rest of the state, São Luís presents better socioeconomic conditions and health service network, which may have sparked a feeling that the worst has passed and consequently reduced the population desire for the vaccine. In smaller cities, the epidemic may have outlined the negative perceptions about health and socioeconomic conditions and local healthcare systems, instilling hope for the covid-19 vaccine protective potential. International studies offered similar explanations, associating covid-19 vaccine rejection with pandemic dynamics and socioeconomic status 9,10,23 .

Many studies addressing vaccine hesitancy include within its drivers individual factors such as emotions, values, risk perceptions, knowledge, and beliefs, which depend on gender, age, and religion 11 . Although we found these factors to be associated with vaccine hesitancy, these findings differ from part of the available literature. In Turkey 23 , women hesitated more than men to the covid-19 vaccine, but no association was found in the United Kingdom 23 .

A study conducted with the most populous countries in the world found men to be more likely to reject the vaccine 9 . Two surveys performed in North America 10, 13 found an association between women and vaccine hesitancy. Regardless of this heterogeneity, women may hesitate more because, while searching for information on vaccines to make health decisions for their children, they may be exposed to anti-vaccination content online 23 . A study addressing the rejection of other vaccines reported similar explanations 26 . Yet another reason for the higher vaccine hesitancy among women is that men, having a greater participation in labor markets outside their homes, may feel at a greater risk of exposure to the virus, thus wishing for more vaccine-induced immunity.

Studies on hesitancy towards a vaccine for covid-19 9,10,24 or other diseases 8,10 found older adults to be less likely than younger adults to present such behavior -different from what we observed in this survey. This discrepancy may be explained by the socioeconomic differences between older adults from Maranhão and those from high-income countries, as well as by how they perceive the pandemic from the media and political discourses. In Maranhão, aging occurs in situations of poverty and greater social needs than those observed in most Brazilian states. This population low functional literacy hinders their understanding about the role and importance of health measures such as self-care and immunization 27 .

Moreover, social isolation may have had opposite effects in this population -on the one hand, they were less exposed to consultations and health professionals; on the other, they were more exposed to traditional news and social media coverage about the covid-19. In that context, older adults became less likely to acquire reliable information, more suitable to their understanding on health. Brazilian troubled political environment in coping with the pandemic may also have shaken older adults' confidence in the information provided about the covid-19 pandemic and vaccine 8, 10, 13, 24, 27 .

As observed in other countries, religion also played a role in the covid-19 vaccine rejection and low compliance with non-pharmacological interventions (NPI) 13, 28 . Since the pandemic onset, a considerable amount of misinformation and conspiracy theories has been spread through social media, following the coronavirus spread itself, affecting especially certain religious groups. Religious beliefs may play either constructive or harmful roles in a pandemic scenario, impacting people's behavior. In negative terms, religious fundamentalism helps spreading misinformation and preaches religious attitudes based exclusively on faith as a guarantee of protection against covid-19 (prayers, fasts, and trust in the divine will) 13, 28 . Religious leaders are pivotal in establishing social norms and stimulating individual and collective responses to NPI and vaccine acceptance 13, 28 .

In several countries (Brazil included), discourses of denial made by religious leaders, based on conspiracy theories and misinformation, jeopardized public health communications and harmed epidemic control 28 .

In our study, we found people without self-reported symptoms to be more prone to vaccine hesitancy than those who reported experiencing any symptoms, or even associated with covid-19 diagnosis. Studies show that people without or with few symptoms may have lower perceptions of the risk, complications, or severity of covid-19 than those who experienced typical or severe forms of the disease 13, 25 . Such perception may likewise reflect the access to inaccurate information regarding the pandemic and its current dynamics. The reopening of non-essential retail outlets and the discourses of some political and religious leaders, classifying the disease as of lesser clinical relevance and devaluing its epidemiological impact, may have shaped the popular notion that covid-19 is easy to control and poses but a low risk, so that immunization would not be as necessary 13, 28 .

Our study has some limitations. Being a cross-sectional survey, we faced difficulties in establishing the direction of associations. However, most variables in this study were demographic, so that we may assume that vaccine hesitancy depends more on them than the other way around. In our study, education level and income were not associated with the outcome, differing from that reported in other studies in the literature 9, 13 . Data on compliance with NPI and the use of public transportation during the pandemic was self-reported, thus incurring memory bias and possibly justifying the lack of association with the studied outcome. Likewise, symptoms were investigated through recall, according to the month in which they were experienced. However, symptoms frequency was investigated based on those more associated with covid-19 diagnosis -anosmia/ hyposmia or ageusia/dysgeusia 16 . Regarding vaccination intention, the questionnaire was administered when vaccination had not yet begun, so that few details on how it would be performed had been disclosed by then. The survey was conducted when most retail outlets were already reopened, and not at the peak of the pandemic, which may have influenced how individuals perceive vaccine. Despite these limitations, the results arise from a representative sample of the state of Maranhão, considering its municipalities different population sizes.

Our results indicate a relevant prevalence of vaccine hesitancy in Maranhão, which is associated with individual, contextual, and clinical factors. We also identified the groups and contexts of greatest resistance, requiring special attention from public strategies to ensure wide vaccination. For that, authorities must prepare the population with more

Intervenções não farmacológicas para o enfrentamento à epidemia da COVID-19 no Brasil

Communication from the Commission to The European Parliament, The European Council, The Council and The European Investment Bank EU Strategy for COVID-19 vaccines. Brussels: EC; 2020

World Health Organization. Ten threats to global health in 2019

Informações de Saúde (TABNET): imunizações -cobertura -Brasil. Brasíia, DF: DATASUS; 2020

OPAS pede que países mantenham programas de vacinação durante pandemia de COVID-19

European Centre for Disease Prevention and Control. Catalogue of interventions addressing vaccine hesitancy: technical report. Copenhagen: ECDC

Vaccine hesitancy: a generation at risk

Vaccine confidence and hesitancy in Brazil

A global survey of potential acceptance of a COVID-19 vaccine

Determinants of COVID-19 vaccine acceptance in the US

How can a global pandemic affect vaccine hesitancy?

Coronavirus vaccine tracker. The New York Times

Key guidelines in developing a pre-emptive COVID-19 vaccination uptake promotion strategy

Vaccine confidence in the time of COVID-19

Estimativas da população 2019

Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão

Factors associated with covid-19 vaccine hesitancy

Censo demográfico e contagem da população: população residente, por cor ou raça, segundo a situação do domicílio, o sexo e a idade

EpiCollect: linking smartphones to web applications for epidemiology, ecology and community data collection

Development and validation of the Elecsys Anti-SARS-CoV-2 immunoassay as a highly specific tool for determining past exposure to SARS-CoV-2

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

Addressing vaccine hesitancy: clinical guidance for primary care physicians working with parents

Qual a importância da hesitação vacinal na queda das coberturas vacinais no Brasil?

COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey

Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults

Vaccine hesitancy: the next challenge in the fight against COVID-19

Vaccine rejection and hesitation in Turkey

COVID-19 and health literacy: the yell of a silent epidemic amidst the pandemic

Effects of misinformation on COVID-19 individual responses and recommendations for resilience of disastrous consequences of misinformation

Funding: Health Department of Maranhão and Coordination for the Improvement of Higher Education Personnel (CAPES -Funding Code 001, Brazil)